<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Muller DC</submitter><funding>Cancer Research UK</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>k4981</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6315896</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>364</volume><pubmed_abstract>&lt;h4>Objectives&lt;/h4>To conduct a comprehensive analysis of prospectively measured circulating high sensitivity C reactive protein (hsCRP) concentration and risk of lung cancer overall, by smoking status (never, former, and current smokers), and histological sub-type.&lt;h4>Design&lt;/h4>Nested case-control study.&lt;h4>Setting&lt;/h4>20 population based cohort studies in Asia, Europe, Australia, and the United States.&lt;h4>Participants&lt;/h4>5299 patients with incident lung cancer, with individually incidence density matched controls.&lt;h4>Exposure&lt;/h4>Circulating hsCRP concentrations in prediagnostic serum or plasma samples.&lt;h4>Main outcome measure&lt;/h4>Incident lung cancer diagnosis.&lt;h4>Results&lt;/h4>A positive association between circulating hsCRP concentration and the risk of lung cancer for current (odds r</pubmed_abstract><journal>BMJ (Clinical research ed.)</journal><pubmed_title>Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.</pubmed_title><pmcid>PMC6315896</pmcid><funding_grant_id>24390</funding_grant_id><funding_grant_id>UM1 CA182910</funding_grant_id><funding_grant_id>U01 CA164973</funding_grant_id><funding_grant_id>UM1 CA182934</funding_grant_id><funding_grant_id>HHSN268201600002C</funding_grant_id><funding_grant_id>U01 CA155340</funding_grant_id><funding_grant_id>UM1 CA173640</funding_grant_id><funding_grant_id>HHSN268201600003C</funding_grant_id><funding_grant_id>HHSN268201600001C</funding_grant_id><funding_grant_id>HHSN268201600018C</funding_grant_id><funding_grant_id>HHSN268201600004C</funding_grant_id><pubmed_authors>Hodge A</pubmed_authors><pubmed_authors>Cai Q</pubmed_authors><pubmed_authors>Sesso HD</pubmed_authors><pubmed_authors>Thomson CA</pubmed_authors><pubmed_authors>Severi G</pubmed_authors><pubmed_authors>Guida F</pubmed_authors><pubmed_authors>Hoffman Bolton J</pubmed_authors><pubmed_authors>Le Marchand L</pubmed_authors><pubmed_authors>Weinstein SJ</pubmed_authors><pubmed_authors>Ueland PM</pubmed_authors><pubmed_authors>Hveem K</pubmed_authors><pubmed_authors>Koh WP</pubmed_authors><pubmed_authors>Visvanathan K</pubmed_authors><pubmed_authors>Langhammer A</pubmed_authors><pubmed_authors>Grankvist K</pubmed_authors><pubmed_authors>Giles GG</pubmed_authors><pubmed_authors>Caporaso NE</pubmed_authors><pubmed_authors>Midttun O</pubmed_authors><pubmed_authors>Zeleniuch-Jacquotte A</pubmed_authors><pubmed_authors>Engstrom G</pubmed_authors><pubmed_authors>Yuan JM</pubmed_authors><pubmed_authors>Larose TL</pubmed_authors><pubmed_authors>Brennan P</pubmed_authors><pubmed_authors>Milne RL</pubmed_authors><pubmed_authors>Muller DC</pubmed_authors><pubmed_authors>Brunnstrom H</pubmed_authors><pubmed_authors>Buring JE</pubmed_authors><pubmed_authors>Shu XO</pubmed_authors><pubmed_authors>Meyer K</pubmed_authors><pubmed_authors>Purdue MP</pubmed_authors><pubmed_authors>Stampfer MJ</pubmed_authors><pubmed_authors>Zheng W</pubmed_authors><pubmed_authors>Arslan AA</pubmed_authors><pubmed_authors>Albanes D</pubmed_authors><pubmed_authors>Lee IM</pubmed_authors><pubmed_authors>Prentice RL</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Xiang YB</pubmed_authors><pubmed_authors>Stevens VL</pubmed_authors><pubmed_authors>Johansson M</pubmed_authors><pubmed_authors>Gaziano JM</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>Blot WJ</pubmed_authors><pubmed_authors>Pettinger M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium.</name><description>&lt;h4>Objectives&lt;/h4>To conduct a comprehensive analysis of prospectively measured circulating high sensitivity C reactive protein (hsCRP) concentration and risk of lung cancer overall, by smoking status (never, former, and current smokers), and histological sub-type.&lt;h4>Design&lt;/h4>Nested case-control study.&lt;h4>Setting&lt;/h4>20 population based cohort studies in Asia, Europe, Australia, and the United States.&lt;h4>Participants&lt;/h4>5299 patients with incident lung cancer, with individually incidence density matched controls.&lt;h4>Exposure&lt;/h4>Circulating hsCRP concentrations in prediagnostic serum or plasma samples.&lt;h4>Main outcome measure&lt;/h4>Incident lung cancer diagnosis.&lt;h4>Results&lt;/h4>A positive association between circulating hsCRP concentration and the risk of lung cancer for current (odds r</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Jan</publication><modification>2025-04-04T12:41:48.575Z</modification><creation>2019-03-26T22:36:50Z</creation></dates><accession>S-EPMC6315896</accession><cross_references><pubmed>30606716</pubmed><doi>10.1136/bmj.k4981</doi></cross_references></HashMap>